Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone
- PMID: 7438892
Item in Clipboard
Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone
Chronobiologia.
1980 Jan-Mar.
No abstract available
Similar articles
-
Combined chronochemotherapy of L1210 leukemic mice using 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine, methylprednisolone and cis-diamminedichloroplatinum.Chronobiologia. 1980 Jan-Mar;7(1):33-40. Chronobiologia. 1980. PMID: 7192203
-
Survival and cure of leukemic mice after circadian optimization of treatment with cyclophosphamide and 1-beta-D-arabinofuranosylcytosine.Cancer Res. 1977 Oct;37(10):3648-55. Cancer Res. 1977. PMID: 908013
-
Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.Biomedicine. 1974 Dec 10;21(12):471-9. Biomedicine. 1974. PMID: 4462870 No abstract available.
-
Factors pertaining to complete drug-induced remission of tumor in animals and man.Cancer Res. 1969 Dec;29(12):2285-91. Cancer Res. 1969. PMID: 4917976 Review. No abstract available.
-
Ifosfamide in experimental tumor systems.Semin Oncol. 1982 Dec;9(4 Suppl 1):14-23. Semin Oncol. 1982. PMID: 6761864 Review. No abstract available.
Cited by
-
The effect of abolition of the endogenous corticosteroid rhythm on the circadian variation in methotrexate toxicity in the rat.Cancer Chemother Pharmacol. 1987;19(4):287-90. doi: 10.1007/BF00261474. Cancer Chemother Pharmacol. 1987. PMID: 3594715
-
The effect of timing of a single injection on the toxicity of methotrexate in the rat.Cancer Chemother Pharmacol. 1982;9(2):114-7. doi: 10.1007/BF00265390. Cancer Chemother Pharmacol. 1982. PMID: 7172405